Oak HC/FT
VC Fund
Greenwich, United States
Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology. The firm focuses on driving transformation in these industries by providing entrepreneurs and companies with strategic counsel, board-level participation, and access to our extensive network of industryleaders.Oak HC/FT partners are peerless in delivering returns for investors and growing innovative businesses. Over the past decade, the partners at Oak HC/FT have had 20 realizations with 6 companies achieving valuations in excess of $1 billion.Oak HC/FT is led by the Healthcare and FinTech team of Oak Investment Partners as part of Oak’s strategy to develop sector-specific funds and continue its legacy of building best-in-class businesses.
- Total investments:
- 205
- Last investment:
- Lead investor:
- 55%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Oak HC/FT invests in
Stages Oak HC/FT invests in
Countries Oak HC/FT invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $12M–$100M
- Series B
- $18M–$120M
- Series C
- $20M–$136M
Investment Focus
Industry
- Health Care 54 (26%)
- Software 23 (11%)
- FinTech 20 (10%)
- Information Technology 19 (9%)
- Artificial Intelligence 18 (9%)
Stage
- Series B 50 (24%)
- Series C 35 (17%)
- Series A 29 (14%)
- Funding Round 16 (8%)
- Series D 14 (7%)
Country
- United States 87 (42%)
- Israel 5 (2%)
- United Kingdom 3 (1%)
- Canada 2 (1%)
- Mexico 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andrew Adams
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 26 | Find email | |
Annie Lamont
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 31 | Find email | |
Billy Deitch
Partner
|
Partner | Total investments: 9 | Find email | |
Eliza Adams
Investor
|
Investor | Total investments: 0 | Find email | |
Michael Heller
Venture Partner
|
Venture Partner | Total investments: 4 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dash Bio
|
Dash Bio is a modern automated platform. It is redesigning drug development from the ground up, using AI, robotics, and fully integrated software to fundamentally change the way medications are brought to market. | $30M / Series A / Aug 03, 2026 | |
Candid Health
|
Candid Health develops software that supports healthcare organizations in managing revenue cycle operations. Its platform automates and coordinates processes such as medical coding, claims submission, payment posting, denial management, and reimbursement workflows. The company integrates with electronic health record and practice management systemsto facilitate the exchange of clinical and billing data across healthcare providers and payers. It provides tools that enable healthcare organizations to monitor billing performance, identify claim issues, and manage revenue cycle activities through a centralized system. The company also offers analytics and workflow capabilities that support administrative and financial operations within healthcare practices. | $120M / Series D / Jul 22, 2026 | |
Cordant
|
Cordant serves as the connective operational fabric for modern financial infrastructure. Operating as a shared context layer above existing legacy systems, it enables institutions to analyze activity, surface underlying risk, and coordinate critical payment decisions in real time. The platform provides a single operational picture acrossdisconnected networks to help risk and treasury teams remain proactive rather than reactive. | $8M / Seed / Jul 21, 2026 | |
Chai Discovery
|
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiplesequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | $400M / Series C / Jul 14, 2026 | |
Corner Health
|
Operator of a nurse practitioner management platform intended to empower nurses to start and manage their independent practices. | $25M / Series A / Jul 13, 2026 | |
|
Corner Health
|
Operator of a nurse practitioner management platform intended to empower nurses to start and manage their independent practices. | $25M / Series A / Jul 13, 2026 | |
Auger
|
Auger develops an AI-powered tool that integrates with existing inventory management systems to provide real-time insights for supply chain-dependent businesses. Auger integrates data from multiple sources, using advanced AI and machine learning to generate real-time automated, dynamic insights. The platform provides a unified view across planning,forecasting, and financing, allowing teams to move beyond manual tasks and concentrate on driving innovation. | $50M / Series B / Jul 09, 2026 | |
Stepful
|
Stepful is an online learning platform that provides training programs for entry-level healthcare careers such as medical assistant, pharmacy technician, dental assistant, and related roles. It delivers its courses through live, instructor-led virtual classes, interactive assignments, and structured exam preparation for nationally recognizedcertifications. The platform also includes in-person clinical or externship components arranged through partner healthcare providers to help students gain practical experience. Stepful supports learners with additional services such as career coaching, resume preparation, and job search assistance after certification. Overall, it is designed to help students transition into healthcare roles by combining online instruction with hands-on training and employment support. | $55M / Series C / Jun 08, 2026 | |
|
Auger
|
Auger develops an AI-powered tool that integrates with existing inventory management systems to provide real-time insights for supply chain-dependent businesses. Auger integrates data from multiple sources, using advanced AI and machine learning to generate real-time automated, dynamic insights. The platform provides a unified view across planning,forecasting, and financing, allowing teams to move beyond manual tasks and concentrate on driving innovation. | $200M / Series A / Jun 03, 2026 | |
Catena Labs
|
Catena Labs incubate independent products spanning identity, communications, AI, and commerce. The company's mission is to empower people with agency, safety, value, and joy online. | $30M / Series A / May 20, 2026 | |
| See all 205 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Oak HC/FT invest in?
Oak HC/FT invests primarily in Health Care, Software and FinTech startups, most often at Series B and Series C stage. Most of the 205 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Oak HC/FT's check size?
Oak HC/FT typically joins rounds of $12M–$100M at Series A, $18M–$120M at Series B and $20M–$136M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oak HC/FT participates in.
How do I contact Oak HC/FT?
Public channels for Oak HC/FT include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oak HC/FT?
The team at Oak HC/FT includes Andrew Adams (Co-Founder & Managing Partner), Annie Lamont (Co-Founder & Managing Partner) and Billy Deitch (Partner), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
